CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

“The GLP-1 landscape is expected to broaden significantly,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in Cary, North Carolina. “For the first time, medical ...

A key to the pill's success will be attracting cash-paying consumers who cannot obtain insurance coverage, a stark shift from ...

The weight loss drug market is bracing itself for a transformative year in 2026, with significant changes anticipated for GLP ...

Six of the clinical trials involved semaglutide — the ingredient used in Novo Nordisk's brands Ozempic and Wegovy — and ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Kanagawa University of Human Services-led researchers found short-term BMI reductions after an eight-to-12-week ...